Apollo gains CE marking for new endoscopic indications, with the OverStitch system, including ESG
Apollo Endosurgery has gained CE marking for new endoscopic indications, with the OverStitch system, including endoscopic gastric sleeve...
top of page
Browse by category
Search
Boston Scientific agree to acquire Apollo Endosurgery for US$615 million
Boston Scientific has entered into a definitive agreement to acquire Apollo Endosurgery, for a cash price of $10 per share, reflecting an...
Apollo’s ESG and REVISE Systems approved by FDA
Apollo Endosurgery has been granted marketing authorisation for its ESG, ESG Sx, REVISE and REVISE Sx through the FDA’s De Novo...
MERIT: Endoscopic sleeve gastroplasty study meets primary endpoints
Study investigators of the Multi-Center Endoscopic Sleeve Gastroplasty (ESG) Randomized Interventional Trial (MERIT) have announced that...
MERIT: ESG achieves primary efficacy and safety endpoints
Investigators of the Multi-Center ESG Randomized Interventional (MERIT) study, which is comparing Endoscopic Sleeve Gastroplasty (ESG) to...
X-Tack is superior for acute closure of large resection defects vs TTS clips
Rescue therapy with X-Tack following failed closure with TTS clips and X-Tack closure of a colonic perforation. a Failed closure attempt...
Apollo Endosurgery gains CPT Codes for use in intragastric balloon procedures
Apollo Endosurgery has gained the assignment of Category I Current Procedural Terminology (CPT) codes with short form descriptor...
FDA grants Breakthrough Device Designation for Apollo’s Orbera Balloon for NASH treatment
Apollo Endosurgery has received a Breakthrough Device Designation from the FDA for the Orbera Intragastric Balloon, specifically for the...
FDA clears Apollo Endosurgery’s X-Tack Endoscopic HeliX Tacking System
Apollo Endosurgery has gained FDA 510k clearance of the X-Tack Endoscopic HeliX Tacking System, a new, through-the-scope, suture-based...
Browse by tag
bottom of page